Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCytosorbents Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$1.03 | -$0.92 | -$0.97 |
| Q2 2026 | 2 | -$0.84 | -$0.72 | -$0.78 |
| Q3 2026 | 2 | -$1.00 | -$0.80 | -$0.90 |
| Q4 2026 | 2 | -$0.80 | -$0.60 | -$0.70 |
| Q1 2027 | 1 | $0.01 | $0.01 | $0.01 |
| Q2 2027 | 1 | $0.01 | $0.01 | $0.01 |
| Q3 2027 | 1 | $0.19 | $0.21 | $0.20 |
| Q4 2027 | 1 | -$0.21 | -$0.19 | -$0.20 |
| Q1 2028 | 1 | $0.52 | $0.59 | $0.55 |
| Q2 2028 | 1 | $0.54 | $0.61 | $0.57 |
| Q3 2028 | 1 | $0.58 | $0.66 | $0.62 |
| Q4 2028 | 1 | $0.60 | $0.69 | $0.65 |
Cytosorbents Corp Earnings Date And Information
Cytosorbents Corp last posted its earnings results on Thursday, August 6th, 2026. The company reported $-1.4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.8 by $0.6. The company had revenue of 9.63 M for the quarter and had revenue of 37.06 M for the year. Cytosorbents Corp has generated $-3 earnings per share over the last year ($-2.6 diluted earnings per share) and currently has a price-to-earnings ratio of -0.65. Cytosorbents Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Cytosorbents Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$0.80 | -$1.40 | -0.6 | $9.39 M | $9.63 M |
| 05/13/2026 | Q1 2026 | -$0.06 | -$1.60 | -1.54 | $9.35 M | $8.86 M |
| 03/30/2026 | Q4 2025 | N/A | -$1.75 | N/A | $9.59 M | $9.23 M |
| 11/13/2025 | Q3 2025 | -$1.20 | -$1.00 | 0.2 | $10.40 M | $9.49 M |
| 08/07/2025 | Q2 2025 | -$0.07 | $0.62 | 0.69 | $9.23 M | $9.62 M |
| 05/14/2025 | Q1 2025 | -$1.60 | -$0.49 | 1.11 | $9.01 M | $8.73 M |
| 03/31/2025 | Q4 2024 | N/A | -$2.80 | N/A | $10.10 M | $9.15 M |
| 11/07/2024 | Q3 2024 | -$1.20 | -$0.86 | 0.34 | $10.36 M | $8.61 M |
| 08/13/2024 | Q2 2024 | -$2.00 | -$1.53 | 0.47 | $9.68 M | $8.84 M |
| 05/09/2024 | Q1 2024 | -$2.40 | -$2.20 | 0.2 | $9.80 M | $8.99 M |
| 03/14/2024 | Q4 2023 | N/A | -$2.60 | N/A | $9.28 M | $7.35 M |
| 11/09/2023 | Q3 2023 | -$2.40 | -$4.20 | -1.8 | $9.50 M | $7.75 M |
| 08/01/2023 | Q2 2023 | -$2.20 | -$2.80 | -0.6 | $11.03 M | $9.42 M |
| 05/02/2023 | Q1 2023 | -$2.53 | -$3.40 | -0.87 | $8.74 M | $9.45 M |
| 03/09/2023 | Q4 2022 | -$3.40 | -$0.35 | 3.05 | $8.71 M | $9.39 M |
| 11/03/2022 | Q3 2022 | -$3.20 | -$5.60 | -2.4 | $8.97 M | $6.46 M |
| 08/02/2022 | Q2 2022 | -$2.67 | -$5.00 | -2.33 | $9.58 M | $8.50 M |
| 05/03/2022 | Q1 2022 | -$2.40 | -$4.20 | -1.8 | $9.72 M | $7.92 M |
| 03/10/2022 | Q4 2021 | N/A | -$4.40 | N/A | $9.68 M | $10.78 M |
| 11/04/2021 | Q3 2021 | -$2.40 | -$3.00 | -0.6 | $9.70 M | $8.90 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytosorbents Corp Earnings: FAQ's
The conference call for Cytosorbents Corp's latest earnings report can be listened to online.
The conference call transcript for Cytosorbents Corp's latest earnings report can be read online.
Cytosorbents Corp (:CTSO) has a recorded annual revenue of $37.06 M.
Cytosorbents Corp (:CTSO) has a recorded net income of $-8,198,000.Cytosorbents Corp has generated $-2.6 earnings per share over the last four quarters.
Cytosorbents Corp (:CTSO) has a price-to-earnings ratio of -0.65 and price/earnings-to-growth ratio is 0.01.